Research Information System
NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.48, no.1, pp.72-74, 2014 (ESCI, Scopus)
F-18-NaF was used as a bone-seeking PET tracer for skeletal imaging until the introduction of the widely available Tc-99m-labeled bone agents. However, there is renewed clinical interest in F-18-NaF since prior technical and logistic limitations to its routine use are no longer present, and, as a consequence, it is likely that uptake unrelated to bone and non-osseous findings will be encountered more frequently. As a result of tumoral necrosis, soft tissue metastases may demonstrate F-18-NaF avidity due to dystrophic calcification. On the other hand, all non-osseous findings, whether F-18-NaF avid or not, may provide important diagnostic information that may alter the course of the disease, including treatment options. Herein we present a patient with ductal carcinoma of the breast in whom findings unrelated to the skeletal system in F-18-NaF PET/CT altered the treatment strategy.